Greg Bryant

Greg Bryant is a professional with a background in finance and extensive experience in the biopharma industry. Greg has held various leadership roles in companies such as Tempus AI, 23andMe, and CitrusLabs. Greg has expertise in commercial partnerships, business development, clinical trials, and key account management. Greg has a Master's degree in Applied Finance from FINSIA, a Bachelor's degree in Finance from Politecnico di Milano, and another Bachelor's degree in Business Finance from RMIT University.